BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 25120753)

  • 1. Co-expression of uPAR and CXCR4 promotes tumor growth and metastasis in small cell lung cancer.
    Li Y; Shen Y; Miao Y; Luan Y; Sun B; Qiu X
    Int J Clin Exp Pathol; 2014; 7(7):3771-80. PubMed ID: 25120753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of molecular factors correlated with metastasis in small cell lung cancer and their significance.
    Li XX; Li RJ; Zhao LJ; Liu NB; Wang P
    Int J Clin Exp Pathol; 2015; 8(11):14676-84. PubMed ID: 26823791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subpopulations of uPAR+ contribute to vasculogenic mimicry and metastasis in large cell lung cancer.
    Li Y; Sun B; Zhao X; Zhang D; Wang X; Zhu D; Yang Z; Qiu Z; Ban X
    Exp Mol Pathol; 2015 Apr; 98(2):136-44. PubMed ID: 25661888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Influence of overexpressed coagulant and fibrolytic components in tumor tissues on the prognosis of non-small cell lung cancer].
    Chen WH; Wang C; Zhang YH; Yang YH; Zhan HY; Zhang LM
    Zhonghua Yi Xue Za Zhi; 2007 Dec; 87(45):3228-32. PubMed ID: 18399120
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Significance of expression of chemokine receptor and matrix metalloproteinase in small cell lung cancer].
    Li RJ; Zhao LJ; Zhan ZL; Lü X; Gong LL; Wang P
    Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(8):532-5. PubMed ID: 22490156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinicopathological and prognostic significance of HIF-1α and HIF-2α expression in small cell lung cancer.
    Luan Y; Gao C; Miao Y; Li Y; Wang Z; Qiu X
    Pathol Res Pract; 2013 Mar; 209(3):184-9. PubMed ID: 23375698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ADAM-12 as a diagnostic marker for the proliferation, migration and invasion in patients with small cell lung cancer.
    Shao S; Li Z; Gao W; Yu G; Liu D; Pan F
    PLoS One; 2014; 9(1):e85936. PubMed ID: 24465799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Downregulation of CXCR4 by SDF-KDEL in SBC-5 cells inhibits their migration in vitro and organ metastasis in vivo.
    Ma N; Pang H; Shen W; Zhang F; Cui Z; Wang J; Wang J; Liu L; Zhang H
    Int J Mol Med; 2015 Feb; 35(2):425-32. PubMed ID: 25504108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Somatostatin and CXCR4 expression patterns in adenocarcinoma and squamous cell carcinoma of the lung relative to small cell lung cancer.
    Stumpf C; Kaemmerer D; Neubauer E; Sänger J; Schulz S; Lupp A
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1921-1932. PubMed ID: 30076481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urokinase-type plasminogen activator receptor (uPAR) expression is associated with T-stage and survival in urothelial carcinoma of the bladder.
    Dohn LH; Illemann M; Høyer-Hansen G; Christensen IJ; Hostmark J; Litlekalsoy J; von der Maase H; Pappot H; Laerum OD
    Urol Oncol; 2015 Apr; 33(4):165.e15-24. PubMed ID: 25575713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differential expression and prognostic value of the chemokine receptor CXCR4 in bronchopulmonary neuroendocrine neoplasms.
    Kaemmerer D; Reimann C; Specht E; Wirtz RM; Sayeg M; Baum RP; Schulz S; Lupp A
    Oncotarget; 2015 Feb; 6(5):3346-58. PubMed ID: 25671300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of uPAR-positive chemoresistant cells in small cell lung cancer.
    Gutova M; Najbauer J; Gevorgyan A; Metz MZ; Weng Y; Shih CC; Aboody KS
    PLoS One; 2007 Feb; 2(2):e243. PubMed ID: 17327908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Invasion and metastasis of hepatocellular carcinoma in relation to urokinase-type plasminogen activator, its receptor and inhibitor.
    Zheng Q; Tang ZY; Xue Q; Shi DR; Song HY; Tang HB
    J Cancer Res Clin Oncol; 2000 Nov; 126(11):641-6. PubMed ID: 11079728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MicroRNA-1 attenuates the growth and metastasis of small cell lung cancer through CXCR4/FOXM1/RRM2 axis.
    Khan P; Siddiqui JA; Kshirsagar PG; Venkata RC; Maurya SK; Mirzapoiazova T; Perumal N; Chaudhary S; Kanchan RK; Fatima M; Khan MA; Rehman AU; Lakshmanan I; Mahapatra S; Talmon GA; Kulkarni P; Ganti AK; Jain M; Salgia R; Batra SK; Nasser MW
    Mol Cancer; 2023 Jan; 22(1):1. PubMed ID: 36597126
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Macrophages of M1 phenotype have properties that influence lung cancer cell progression.
    Hedbrant A; Wijkander J; Seidal T; Delbro D; Erlandsson A
    Tumour Biol; 2015 Nov; 36(11):8715-25. PubMed ID: 26050228
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Suppression of metastases of small cell lung cancer cells in mice by a peptidic CXCR4 inhibitor TF14016.
    Otani Y; Kijima T; Kohmo S; Oishi S; Minami T; Nagatomo I; Takahashi R; Hirata H; Suzuki M; Inoue K; Takeda Y; Kida H; Tachibana I; Fujii N; Kumanogoh A
    FEBS Lett; 2012 Oct; 586(20):3639-44. PubMed ID: 22992418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The liberated domain I of urokinase plasminogen activator receptor--a new tumour marker in small cell lung cancer.
    Almasi CE; Drivsholm L; Pappot H; Høyer-Hansen G; Christensen IJ
    APMIS; 2013 Mar; 121(3):189-96. PubMed ID: 23030781
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting of urokinase plasminogen activator receptor in human pancreatic carcinoma cells inhibits c-Met- and insulin-like growth factor-I receptor-mediated migration and invasion and orthotopic tumor growth in mice.
    Bauer TW; Liu W; Fan F; Camp ER; Yang A; Somcio RJ; Bucana CD; Callahan J; Parry GC; Evans DB; Boyd DD; Mazar AP; Ellis LM
    Cancer Res; 2005 Sep; 65(17):7775-81. PubMed ID: 16140945
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin-like epithelial-to-mesenchymal transition inducer activity is controlled by proteolytic processing and plasminogen-urokinase plasminogen activator receptor system-regulated secretion during breast cancer progression.
    Csiszar A; Kutay B; Wirth S; Schmidt U; Macho-Maschler S; Schreiber M; Alacakaptan M; Vogel GF; Aumayr K; Huber LA; Beug H
    Breast Cancer Res; 2014 Sep; 16(5):433. PubMed ID: 25212966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.